Figure 1. MLN2238 treatment of Jurkat... | American Society of Hematology

Figure 1.

Figure 1. MLN2238 treatment of Jurkat (TCL) or L540 (HL) human lymphoma xenografts resulted in significant tumor reduction.

MLN2238 treatment of Jurkat (TCL) or L540 (HL) human lymphoma xenografts resulted in significant tumor reduction.

This Feature Is Available To Subscribers Only

Sign In or Create an Account